China Biologic Products to Upgrade Plasma Production Facilities [View article]
I think a PE (based on 2007 income of .47/share) of 14 is a bit steep- especially for a pink sheet.
LTUS.OB (Lotus Pharmaceuticals) (based on 2007 income of .18/share) is trading at a PE of under 6 at $1/share.
Lotus Pharmaceuticals has the same torrid income and revenue growth (120% and 70% respectively) yoy that China Biologic has also, and is off the pinks.
China Biologic Products to Upgrade Plasma Production Facilities [View article]
LTUS.OB (Lotus Pharmaceuticals) (based on 2007 income of .18/share) is trading at a PE of under 6 at $1/share.
Lotus Pharmaceuticals has the same torrid income and revenue growth (120% and 70% respectively) yoy that China Biologic has also, and is off the pinks.
You might want to do some more dd on LTUS.